K-V PHARMACEUTICAL CO

Profile

Company Names

K-V PHARMACEUTICAL CO
KV PHARMACEUTICAL CO /DE/

Addresses

16640 CHESTERFIELD GROVE ROAD, SUITE 200, CHESTERFIELD, MO 63005

2280 SCHUETZ ROAD, ST. LOUIS, MO 63146

ONE CORPORATE WOODS DRIVE, BRIDGETON, MO 63044

Phone Numbers

3146456600
314-645-6600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$525,977,106.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-06-06 
$260,877,100.00 
$260,877,100.00 
$0.00 
Equity 
4
2012-06-05 
$210,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2011-03-17 
$225,000,000.00 
$225,000,000.00 
$0.00 
Debt 
2
2011-02-17 
$32,337,500.00 
$32,337,500.00 
$0.00 
Equity 
1
2010-11-17 
$7,552,506.00 
$7,552,506.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
E. 
BALDINI 
DIRECTOR
KV PHARMACEUTICAL CO /DE/   |  ACCU-BREAK PHARMACEUTICALS, INC.
GREGORY 
S. 
BENTLEY 
EXECUTIVE OFFICER, DIRECTOR
KV PHARMACEUTICAL CO /DE/
PATRICK 
J 
CHRISTMAS 
EXECUTIVE OFFICER
K-V PHARMACEUTICAL CO
GREGORY 
J 
DIVIS 
EXECUTIVE OFFICER, DIRECTOR
K-V PHARMACEUTICAL CO
GREGORY 
J. 
DIVIS, JR. 
EXECUTIVE OFFICER
KV PHARMACEUTICAL CO /DE/
MARK 
A. 
DOW 
DIRECTOR
KV PHARMACEUTICAL CO /DE/
ERIC 
 
HARON 
DIRECTOR
K-V PHARMACEUTICAL CO
DAVID 
S. 
HERMELIN 
DIRECTOR
KV PHARMACEUTICAL CO /DE/
JOSEPH 
D. 
LEHRER 
DIRECTOR
KV PHARMACEUTICAL CO /DE/
JOE 
 
MCGINNIS 
DIRECTOR
K-V PHARMACEUTICAL CO
THOMAS 
S 
MCHUGH 
EXECUTIVE OFFICER
K-V PHARMACEUTICAL CO
THOMAS 
S. 
MCHUGH 
EXECUTIVE OFFICER
KV PHARMACEUTICAL CO /DE/
STEVE 
 
NIELSON 
DIRECTOR
K-V PHARMACEUTICAL CO
DAVID 
 
SIDRANSKY 
DIRECTOR
ALFACELL CORP   |  KV PHARMACEUTICAL CO /DE/   |  ROSETTA GENOMICS LTD.   |  MORRIA BIOPHARMACEUTICALS PLC   |  CHAMPIONS ONCOLOGY, INC.   |  CELSUS THERAPEUTICS PLC.   |  Y LABS, INC.   |  IMMUNE PHARMACEUTICALS INC   |  ORGENESIS INC.   |  TAMIR BIOTECHNOLOGY, INC.   |  GALMED PHARMACEUTICALS LTD.   |  ISRAEL BIOTECH FUND II, L.P.   |  ADVAXIS, INC.   |  AYALA PHARMACEUTICALS, INC.
JONATHAN 
 
SIEGEL 
DIRECTOR
K-V PHARMACEUTICAL CO   |  DELIVERED.IO, INC.   |  LABCONNECT HOLDINGS, INC.   |  JAGUAR HEALTH, INC.   |  JUNO RESIDENTIAL, INC.   |  XENON INVESTMENT FUND 5, L.P.
ANA 
I. 
STANCIC 
DIRECTOR
CHAMPIONS BIOTECHNOLOGY, INC.   |  KV PHARMACEUTICAL CO /DE/   |  CHAMPIONS ONCOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-09-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
2012-06-18
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-06-05 
2011-04-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-03-17 
2011-03-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-02-17 
2010-12-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2010-11-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
FINANCIAL WEST GROUP
16668
NONE
NONE
JEFFERIES AND COMPANY, INC.
3247